Ontology highlight
ABSTRACT:
SUBMITTER: Magro G
PROVIDER: S-EPMC7305708 | biostudies-literature | 2020 Sep
REPOSITORIES: biostudies-literature
Virus research 20200620
SARS-CoV-2 is the agent responsible for COVID-19. The infection can be dived into three phases: mild infection, the pulmonary phase and the inflammatory phase. Treatment options for the pulmonary phase include: Hydroxychloroquine, Remdesivir, Lopinavir/Ritonavir. The inflammatory phase includes therapeutic options like Tocilizumab, Anakinra, Baricitinib, Eculizumab, Emapalumab and Heparin. Human clinical trials are starting to show some results, in some cases like that of Remdesivir and corticos ...[more]